"gamma-Aminobutyric Acid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The most common inhibitory neurotransmitter in the central nervous system.
| Descriptor ID |
D005680
|
| MeSH Number(s) |
D02.241.081.114.500.350 D12.125.190.350
|
| Concept/Terms |
gamma-Aminobutyric Acid- gamma-Aminobutyric Acid
- gamma Aminobutyric Acid
- GABA
- Aminalon
- Aminalone
- 4-Aminobutanoic Acid
- 4 Aminobutanoic Acid
- 4-Aminobutyric Acid
- 4 Aminobutyric Acid
|
Below are MeSH descriptors whose meaning is more general than "gamma-Aminobutyric Acid".
Below are MeSH descriptors whose meaning is more specific than "gamma-Aminobutyric Acid".
This graph shows the total number of publications written about "gamma-Aminobutyric Acid" by people in this website by year, and whether "gamma-Aminobutyric Acid" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 1 | 2 |
| 1997 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2001 | 2 | 0 | 2 |
| 2002 | 2 | 2 | 4 |
| 2005 | 2 | 2 | 4 |
| 2006 | 0 | 2 | 2 |
| 2007 | 1 | 2 | 3 |
| 2008 | 2 | 2 | 4 |
| 2009 | 1 | 3 | 4 |
| 2010 | 6 | 2 | 8 |
| 2012 | 3 | 2 | 5 |
| 2013 | 1 | 2 | 3 |
| 2014 | 2 | 4 | 6 |
| 2016 | 0 | 2 | 2 |
| 2017 | 0 | 2 | 2 |
| 2018 | 0 | 1 | 1 |
| 2022 | 0 | 2 | 2 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "gamma-Aminobutyric Acid" by people in Profiles.
-
Bang JW, Parra C, Yu K, Wollstein G, Schuman JS, Chan KC. GABA decrease is associated with degraded neural specificity in the visual cortex of glaucoma patients. Commun Biol. 2023 06 29; 6(1):679.
-
Nayak AP, An SS. Anxiolytics for Bronchodilation: Refinements to GABAA Agonists for Asthma Relief. Am J Respir Cell Mol Biol. 2022 Oct; 67(4):419-420.
-
Dalakas MC. Stiff-person Syndrome and GAD Antibody-spectrum Disorders: GABAergic Neuronal Excitability, Immunopathogenesis and Update on Antibody Therapies. Neurotherapeutics. 2022 04; 19(3):832-847.
-
Pitchon DN, Dayan AC, Schwenk ES, Baratta JL, Viscusi ER. Updates on Multimodal Analgesia for Orthopedic Surgery. Anesthesiol Clin. 2018 Sep; 36(3):361-373.
-
Kurd MF, Kreitz T, Schroeder G, Vaccaro AR. The Role of Multimodal Analgesia in Spine Surgery. J Am Acad Orthop Surg. 2017 Apr; 25(4):260-268.
-
R Wyrofsky R, Reyes BAS, Van Bockstaele EJ. Co-localization of the cannabinoid type 1 receptor with corticotropin-releasing factor-containing afferents in the noradrenergic nucleus locus coeruleus: implications for the cognitive limb of the stress response. Brain Struct Funct. 2017 Sep; 222(7):3007-3023.
-
Weinstein ZM, Cheng DM, Quinn E, Hui D, Kim H, Gryczynski G, Samet JH. Psychoactive medications and disengagement from office based opioid treatment (obot) with buprenorphine. Drug Alcohol Depend. 2017 Jan 01; 170:9-16.
-
Choudhry DK, Brenn BR, Sacks K, Reichard K. Continuous chest wall ropivacaine infusion for analgesia in children undergoing Nuss procedure: a comparison with thoracic epidural. Paediatr Anaesth. 2016 Jun; 26(6):582-9.
-
Volk DW, Chitrapu A, Edelson JR, Lewis DA. Chemokine receptors and cortical interneuron dysfunction in schizophrenia. Schizophr Res. 2015 Sep; 167(1-3):12-7.
-
Kalia M, Costa E Silva J. Biomarkers of psychiatric diseases: current status and future prospects. Metabolism. 2015 Mar; 64(3 Suppl 1):S11-5.